New Mammogram Guidelines – Lost public health opportunity?
On Monday, November 16, the U.S. Preventive Services Task Force issued a report modifying previous recommendations for breast cancer screening, now stating that women in their 40s should stop routinely having annual mammograms and older women should cut back to one scheduled exam every other year. The independent government-appointed panel cited evidence that the potential harm to women having annual exams beginning at age 40 outweighs the benefit.
This national discussion has had the potential to become an opportunity for public health to get its message across about the value of population-based positions such as this, and how they can be so difficult for individually-focused Americans to grasp.
Has this happened?
In some cases, yes.
Robert Aronowitz, an internist and at the University of Pennsylvania, wrote in a New York Times piece called Addicted to Mammograms, “you need to screen 1,900 women in their 40s for 10 years in order to prevent one death from breast cancer, and in the process you will have generated more than 1,000 false-positive screens and all the overtreatment they entail. This doesn’t make sense.”
On National Public Radio, Dr. Susan Love, a national expert on cancer prevention tried to reframe the individual consumer-focused concern by saying, “What we really need is to figure out what’s causing breast cancer in these young women and figure out a way to stop it.”
Arne N. Gjorgov, M.D., Ph.D. was more pointed, saying that “the early detection of the disease by whatever means (mammography or self-exam) had nothing to do with a real prevention of the growing numbers and incidence rates of the unabated and ever-rising breast cancer epidemic in the country and worldwide.”
As Barbara Ehrenreich wrote in the Los Angeles Times, leading women’s health groups such as Breast Cancer Action, the National Breast Cancer Coalition and the National Women’s Health Network supported the guidelines and have been warning for years about “the excessive use of screening mammography in the United States, which carries its own dangers and leads to no detectable lowering of breast cancer mortality.”
Ehrenreich argues that “the numbers are increasingly insistent: Routine mammographic screening of women under 50 does not reduce breast cancer mortality in that group.”
“One response to the new guidelines,” she says, has been that “numbers don’t matter — only individuals do — and if just one life is saved, that’s good enough.”
In fact, the debate has been framed by many around “the people v. the bean counters” – or “women and families v. those who are behind the death panels.”
But what about the other message – that of wise and efficient use of dollars toward prevention, improved public health, and identifying and reducing environmental and social causes of cancer in the first place? Why isn’t that that message not getting through?
Is public health losing this golden opportunity to tell its story?
What can be done now?




/ Avg: 3.5 / 2 votes
62 comments




This notion makes sense in terms of number but it certainly doesn’t convince me to call up all the women in my family and tell them to skip a whole year of testing. I can see both sides clearly but until we do have a clear cause of breast cancer I don’t think it’s save to cut spending on this. If money is an issue there are many others ways to save in public health. By downplaying exams women may downplay the seriousness of breast cancer and the threat it plays in some many lives.